Benjamin R. Yerxa, EVP & Chf, Research & Develop at INSPIRE PHARMACEUTICALS INC (ISPH), sold 2,000 shares at $5.01 ($10K) on 2009-08-03, disclosed to the SEC on 2009-08-03.
Scheduled sale ($10k) by EVP & Chf, Research & Develop under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.61 | 100 | $461 | 4.8% |
| 2 | $4.68 | 100 | $468 | 4.9% |
| 3 | $4.71 | 200 | $942 | 9.8% |
| 4 | $4.72 | 300 | $1K | 14.7% |
| 5 | $4.79 | 100 | $479 | 5.0% |
| 6 | $4.82 | 478 |
| $2K |
| 23.9% |
| 7 | $4.84 | 22 | $106 | 1.1% |
| 8 | $4.88 | 200 | $976 | 10.1% |
| 9 | $4.94 | 200 | $988 | 10.3% |
| 10 | $4.96 | 100 | $496 | 5.1% |
| 11 | $5.00 | 100 | $500 | 5.2% |
| 12 | $5.01 | 100 | $501 | 5.2% |
| Total | $4.82 avg | 2,000 | $10K | 100% |
| Filing → |
| IRD | BUY | 2024-11-25 | $10K | — | Filing → |
| CLSD | BUY | 2024-05-15 | $10K | — | Filing → |
| ISPH | SELL | 2010-05-05 | $13K | — | Filing → |